|
|
|
|
| LEADER |
03093nmm a2200601 u 4500 |
| 001 |
EB002214745 |
| 003 |
EBX01000000000000001351706 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
240607 ||| eng |
| 020 |
|
|
|a 9798400258732
|
| 100 |
1 |
|
|a Soto, Mauricio
|
| 245 |
0 |
0 |
|a IMF Engagement on Health Spending Issues in Surveillance and Program Work
|c Mauricio Soto, Geremia Palomba, Carolina Bloch, Nick Carroll, Tohid Atashbar, Deeksha Kale, Baoping Shang, Kiichi Tokuoka, Ruud de Mooij, Guillaume Chabert
|
| 260 |
|
|
|a Washington, D.C.
|b International Monetary Fund
|c 2023
|
| 300 |
|
|
|a 57 pages
|
| 653 |
|
|
|a International Taxation
|
| 653 |
|
|
|a Health
|
| 653 |
|
|
|a Revenue administration
|
| 653 |
|
|
|a Tax Evasion and Avoidance
|
| 653 |
|
|
|a Analysis of Health Care Markets
|
| 653 |
|
|
|a National Government Expenditures and Health
|
| 653 |
|
|
|a Public finance & taxation
|
| 653 |
|
|
|a Monetary economics
|
| 653 |
|
|
|a Health care spending
|
| 653 |
|
|
|a Structure, Scope, and Performance of Government
|
| 653 |
|
|
|a Regulation
|
| 653 |
|
|
|a National Government Expenditures and Related Policies: General
|
| 653 |
|
|
|a Health economics
|
| 653 |
|
|
|a Expenditure
|
| 653 |
|
|
|a National Government Expenditures and Welfare Programs
|
| 653 |
|
|
|a Health: General
|
| 653 |
|
|
|a Health care
|
| 653 |
|
|
|a Health and Inequality
|
| 653 |
|
|
|a Health systems & services
|
| 653 |
|
|
|a Expenditures, Public
|
| 653 |
|
|
|a Public Health
|
| 653 |
|
|
|a Health care reform
|
| 653 |
|
|
|a Tax administration and procedure
|
| 653 |
|
|
|a Health Policy
|
| 653 |
|
|
|a Public Finance
|
| 653 |
|
|
|a Health: Government Policy
|
| 653 |
|
|
|a Fiscal and Monetary Policy in Development
|
| 653 |
|
|
|a Medical care
|
| 700 |
1 |
|
|a Palomba, Geremia
|
| 700 |
1 |
|
|a Bloch, Carolina
|
| 700 |
1 |
|
|a Carroll, Nick
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b IMF
|a International Monetary Fund
|
| 490 |
0 |
|
|a Technical Notes and Manuals
|
| 028 |
5 |
0 |
|a 10.5089/9798400258732.005
|
| 856 |
4 |
0 |
|u https://elibrary.imf.org/view/journals/005/2023/008/005.2023.issue-008-en.xml?cid=541112-com-dsp-marc
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a IMF country teams have become increasingly engaged on health spending issues in surveillance and program work, and more so since the COVID-19 pandemic. The primary objectives of health spending are to improve health outcomes and provide protection to households against high financial costs of health care. The Fund’s engagement on health spending issues is guided by an assessment of its macro-criticality, with the scope and purpose of engagement varying across countries and depending on whether it occurs in surveillance or program contexts. This technical note discusses how to assess the macro-criticality of health spending and reviews appropriate policy responses. The design and implementation of macro-critical health reforms often require specific sectoral knowledge and experience. Thus, this note emphasizes the importance of collaborating with development partners on health policy issues
|